Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine (mRNA-1273) Against Novel Coronavirus
Collaboration goal to enable manufacturing of up to 1 billion doses per year Technology transfer expected to begin in June 2020 First batches of mRNA-1273 expected to be manufactured at Lonza U.S. in July 2020 Collaboration leverages Lonza’s worldwide expertise Mehr